key: cord-1030786-i5qk8erw
authors: Shelef, A.; Dahan, S.; Weizman, S.; Bris, E. Bloemhof
title: P.0434 Pre-existing vitamin D supplementation as a protective factor in COVID-19 infection in elderly schizophrenia and dementia inpatients: a case series
date: 2021-12-30
journal: Eur Neuropsychopharmacol
DOI: 10.1016/j.euroneuro.2021.10.407
sha: 62cbad151275a96c350015e9e720b870c2e0aab7
doc_id: 1030786
cord_uid: i5qk8erw

nan

Pre-existing vitamin D supplementation as a protective factor in COVID-19 infection in elderly schizophrenia and dementia inpatients: a case series [1] , dementia [2] ) as well as schizophrenia [3] . In contrast, high Vitamin D levels are known to augment immune activity and to reduce the severity of viral infections such as influenza virus and COVID19.

Recently, a possible association between the likelihood of Covid-19 infection, Covid-19 severity, and Vitamin D blood levels was reported. An association has been found between low Vitamin D levels and an increased likelihood of Covid-19 infection [ 4 , 5 ] . Furthermore, low Vitamin D levels seem to be linked to higher likelihood of hospitalization and severity of symptoms in Covid-19 infection [4] . Low Vitamin D levels show a tendency to be a potential risk factor for Covid-19 infection and hospitalization, independent of demographic characteristics and medical conditions. Aim: to assess the possible association between Vitamin D long term supplementation and Covid-19 symptomatic severity and complications of Covid-19 infection in elderly psychiatric inpatients, a highest at-risk group. Methods: a retrospective case series study. Demographic and clinical data of 14 elderly Covid-19 positive inpatients, suffering from dementia or schizophrenia, and other medical conditions were extracted from their medical records. All patients were maintained on 800IU daily dose of Vitamin D months prior to the infection(mean = 20 months). The cognitive functioning as measured in Mini-Mental State Examination (MMSE) scores were performed right away at their return from hospitalization due to Covid 19 infection and were compared to the scores six months before infection, using two-tailed paired sample t-test.

Summary: During the month of September 2020, when the second wave of the novel Coronavirus Covid-19 culminated in Israel, an outbreak of the epidemic spread in our Holocaust survivor's elderly residence. 31 patients most probably were exposed to a confirmed Covid-19 positive elderly patients. In result, 14 patients, all suffering from dementia or schizophrenia tested positive and immediately placed in quarantine in Corona departments in general hospitals.

Those elderly patients (mean age 82) were expected to present an aggravated version of the virus, according to their affiliation to the highest at-risk groups. They suffered from schizophrenia, N = 8/14; dementia, N = 6/14 and other at-risk physical illnesses such as diabetes (29%), COPD (7%) and hypertension (57%).

Contrary to the expectations, most of the patients were either asymptomatic (28%) or presented very few symptoms. Only two inpatients needed oxygen support, and only one of them stayed dependent on it after release from a Corona department. No one needed intensive care unit (ICU) intervention No significant difference in cognitive function was observed beforehand and after the infection(mean MMSE 13/30, p-NS). Conclusions: according to our unique case series study preexisting Vitamin D supplementation for a long period before Covid 19 epidemic may reinforce immunity and reduce Covid-19 severity and complications in elderly psychiatric inpatients.

Preexisting comorbidities predicting COVID-19 and mortality in the UK Biobank community cohort

Alzheimer s and Parkinson s diseases predict different COVID-19 outcomes, a UK Biobank study

The COVID-19 global pandemic: implications for people with schizophrenia and related disorders

Low plasma 25 (OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study

Association of vitamin D status and other clinical characteristics with COVID-19 test results